Royal Bank of Canada
ENFN

Royal Bank of Canada’s Enfusion, Inc. ENFN Stock Holding History

Royal Bank of Canada’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69
Closed -$1K – 7487
2025
Q1 		$1K Sell
69
-1,246
-95% -$13.8K ﹤0.01% 6750
2024
Q4 		$13K Sell
1,315
-4,367
-77% -$42.2K ﹤0.01% 6279
2024
Q3 		$55K Sell
5,682
-9,394
-62% -$81.1K ﹤0.01% 5657
2024
Q2 		$129K Buy
15,076
+12,841
+575% +$117K ﹤0.01% 5107
2024
Q1 		$20K Sell
2,235
-9,025
-80% -$79.4K ﹤0.01% 5930
2023
Q4 		$109K Buy
11,260
+6,534
+138% +$61K ﹤0.01% 5570
2023
Q3 		$42K Buy
4,726
+3,141
+198% +$29.8K ﹤0.01% 5873
2023
Q2 		$18K Buy
1,585
+66
+4% +$585 ﹤0.01% 6274
2023
Q1 		$16K Sell
1,519
-2,741
-64% -$30.2K ﹤0.01% 6124
2022
Q4 		$41K Buy
4,260
+3,943
+1,244% +$44.4K ﹤0.01% 6001
2022
Q3 		$4K Buy
317
+173
+120% +$2.11K ﹤0.01% 6834
2022
Q2 		$1K Sell
144
-1,193
-89% -$13.2K ﹤0.01% 7235
2022
Q1 		$17K Sell
1,337
-3,429
-72% -$52.4K ﹤0.01% 6697
2021
Q4 		$99K Buy
+4,766
New +$96.3K ﹤0.01% 5955

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's ENFN Position: Q2 2025 in Review

Royal Bank of Canada sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 69 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $129K in Q2 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Royal Bank of Canada reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 69 Enfusion, Inc. shares in Q2 2025, an estimated $1K.
  • Royal Bank of Canada first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Royal Bank of Canada's Enfusion, Inc. position peaked at $129K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.